Agmatine as a novel candidate for rapid-onset antidepressant response  被引量:1

在线阅读下载全文

作  者:Ana Paula Valverde Anderson Camargo Ana Lúcia S Rodrigues 

机构地区:[1]Department of Biochemistry,Campus Universitário,Center for Biological Sciences,Universidade Federal de Santa Catarina,Florianópolis,SC 88040900,Brazil

出  处:《World Journal of Psychiatry》2021年第11期981-996,共16页世界精神病学杂志

基  金:Supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico,No.310113/2017-2;the CNPq Research Productivity Fellowship.

摘  要:Major depressive disorder(MDD)is a disabling and highly prevalent mood disorder as well as a common cause of suicide.Chronic stress,inflammation,and intestinal dysbiosis have all been shown to play crucial roles in the pathophysiology of MDD.Although conventional antidepressants are widely used in the clinic,they can take weeks to months to produce therapeutic effects.The discovery that ketamine promotes fast and sustaining antidepressant responses is one of the most important breakthroughs in the pharmacotherapy of MDD.However,the adverse psychomimetic/dissociative and neurotoxic effects of ketamine discourage its chronic use.Therefore,agmatine,an endogenous glutamatergic modulator,has been postulated to elicit fast behavioral and synaptogenic effects by stimulating the mechanistic target of rapamycin complex 1 signaling pathway,similar to ketamine.However,recent evidence has demonstrated that the modulation of the NLR family pyrin domain containing 3 inflammasome and gut microbiota,which have been shown to play a crucial role in the pathophysiology of MDD,may also participate in the antidepressant-like effects of both ketamine and agmatine.This review seeks to provide evidence about the mechanisms that may underlie the fast antidepressant-like responses of agmatine in preclinical studies.Considering the anti-inflammatory properties of agmatine,it may also be further investigated as a useful compound for the management of MDD associated with a pro-inflammatory state.Moreover,the fast antidepressant-like response of agmatine noted in animal models should be investigated in clinical studies.

关 键 词:AGMATINE Fast-acting antidepressants KETAMINE Major depressive disorder Microbiota-gut-brain axis NEUROINFLAMMATION 

分 类 号:R971.43[医药卫生—药品]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象